Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1125
https://www.valueinhealthjournal.com/article/S1098-3015(13)03030-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
978
First Page :
A499
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03030-1&doi=10.1016/j.jval.2013.08.1125